nodes	percent_of_prediction	percent_of_DWPC	metapath
Acamprosate—GRIN2C—adrenal cortex—polycystic ovary syndrome	0.0107	0.125	CbGeAlD
Acamprosate—GRM5—endocrine gland—polycystic ovary syndrome	0.00882	0.102	CbGeAlD
Acamprosate—Accidental injury—Metformin—polycystic ovary syndrome	0.00681	0.0481	CcSEcCtD
Acamprosate—SLC36A1—uterus—polycystic ovary syndrome	0.00607	0.0704	CbGeAlD
Acamprosate—SLC36A1—adipose tissue—polycystic ovary syndrome	0.00593	0.0689	CbGeAlD
Acamprosate—GRIN1—endocrine gland—polycystic ovary syndrome	0.00557	0.0646	CbGeAlD
Acamprosate—GRIN2A—adrenal gland—polycystic ovary syndrome	0.00536	0.0622	CbGeAlD
Acamprosate—SLC36A1—adrenal gland—polycystic ovary syndrome	0.00532	0.0618	CbGeAlD
Acamprosate—GRIN2B—endocrine gland—polycystic ovary syndrome	0.00531	0.0617	CbGeAlD
Acamprosate—GRIN2A—vagina—polycystic ovary syndrome	0.00496	0.0576	CbGeAlD
Acamprosate—SLC36A1—female gonad—polycystic ovary syndrome	0.00496	0.0576	CbGeAlD
Acamprosate—SLC36A1—vagina—polycystic ovary syndrome	0.00493	0.0572	CbGeAlD
Acamprosate—Injury—Metformin—polycystic ovary syndrome	0.00476	0.0336	CcSEcCtD
Acamprosate—GRIN2A—endocrine gland—polycystic ovary syndrome	0.00464	0.0539	CbGeAlD
Acamprosate—SLC36A1—endocrine gland—polycystic ovary syndrome	0.00462	0.0536	CbGeAlD
Acamprosate—Migraine—Metformin—polycystic ovary syndrome	0.00431	0.0304	CcSEcCtD
Acamprosate—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00404	0.0285	CcSEcCtD
Acamprosate—Breast disorder—Metformin—polycystic ovary syndrome	0.00395	0.0279	CcSEcCtD
Acamprosate—Abdominal distension—Metformin—polycystic ovary syndrome	0.00381	0.0269	CcSEcCtD
Acamprosate—Influenza—Metformin—polycystic ovary syndrome	0.00378	0.0267	CcSEcCtD
Acamprosate—GABRG2—pituitary gland—polycystic ovary syndrome	0.00378	0.0438	CbGeAlD
Acamprosate—Pancreatitis—Metformin—polycystic ovary syndrome	0.00371	0.0262	CcSEcCtD
Acamprosate—Angina pectoris—Metformin—polycystic ovary syndrome	0.00368	0.026	CcSEcCtD
Acamprosate—Rhinitis—Metformin—polycystic ovary syndrome	0.00303	0.0214	CcSEcCtD
Acamprosate—Hepatitis—Metformin—polycystic ovary syndrome	0.00303	0.0214	CcSEcCtD
Acamprosate—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00301	0.0213	CcSEcCtD
Acamprosate—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00298	0.0211	CcSEcCtD
Acamprosate—GABRB3—pituitary gland—polycystic ovary syndrome	0.0029	0.0337	CbGeAlD
Acamprosate—GRM5—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.00284	0.00368	CbGpPWpGaD
Acamprosate—Immune system disorder—Metformin—polycystic ovary syndrome	0.00273	0.0193	CcSEcCtD
Acamprosate—Chills—Metformin—polycystic ovary syndrome	0.00271	0.0192	CcSEcCtD
Acamprosate—GRM5—G alpha (q) signalling events—GHRL—polycystic ovary syndrome	0.00268	0.00347	CbGpPWpGaD
Acamprosate—Malnutrition—Metformin—polycystic ovary syndrome	0.00263	0.0186	CcSEcCtD
Acamprosate—Flatulence—Metformin—polycystic ovary syndrome	0.0026	0.0183	CcSEcCtD
Acamprosate—Dysgeusia—Metformin—polycystic ovary syndrome	0.00258	0.0182	CcSEcCtD
Acamprosate—Muscle spasms—Metformin—polycystic ovary syndrome	0.00253	0.0179	CcSEcCtD
Acamprosate—GRIN1—Mecp2 and Associated Rett Syndrome—NCOR1—polycystic ovary syndrome	0.00248	0.00321	CbGpPWpGaD
Acamprosate—Tremor—Metformin—polycystic ovary syndrome	0.00247	0.0174	CcSEcCtD
Acamprosate—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00244	0.0173	CcSEcCtD
Acamprosate—GABRB3—Ion channel transport—TRPV6—polycystic ovary syndrome	0.00241	0.00312	CbGpPWpGaD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—polycystic ovary syndrome	0.0024	0.00311	CbGpPWpGaD
Acamprosate—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.00239	0.00309	CbGpPWpGaD
Acamprosate—Malaise—Metformin—polycystic ovary syndrome	0.00238	0.0168	CcSEcCtD
Acamprosate—GABRG2—Ion channel transport—TRPV6—polycystic ovary syndrome	0.00237	0.00306	CbGpPWpGaD
Acamprosate—Syncope—Metformin—polycystic ovary syndrome	0.00236	0.0167	CcSEcCtD
Acamprosate—GRM5—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.00236	0.00305	CbGpPWpGaD
Acamprosate—Palpitations—Metformin—polycystic ovary syndrome	0.00233	0.0164	CcSEcCtD
Acamprosate—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00232	0.0164	CcSEcCtD
Acamprosate—Hypertension—Metformin—polycystic ovary syndrome	0.00227	0.0161	CcSEcCtD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.00226	0.00293	CbGpPWpGaD
Acamprosate—GABRB3—endocrine gland—polycystic ovary syndrome	0.00225	0.0261	CbGeAlD
Acamprosate—Chest pain—Metformin—polycystic ovary syndrome	0.00224	0.0158	CcSEcCtD
Acamprosate—Myalgia—Metformin—polycystic ovary syndrome	0.00224	0.0158	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00223	0.0157	CcSEcCtD
Acamprosate—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.00222	0.00287	CbGpPWpGaD
Acamprosate—Discomfort—Metformin—polycystic ovary syndrome	0.00222	0.0157	CcSEcCtD
Acamprosate—GABRB3—Ion channel transport—SCNN1A—polycystic ovary syndrome	0.00218	0.00282	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.00218	0.00282	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.00215	0.00279	CbGpPWpGaD
Acamprosate—GABRG2—Ion channel transport—SCNN1A—polycystic ovary syndrome	0.00214	0.00277	CbGpPWpGaD
Acamprosate—Infection—Metformin—polycystic ovary syndrome	0.00214	0.0151	CcSEcCtD
Acamprosate—Shock—Metformin—polycystic ovary syndrome	0.00211	0.0149	CcSEcCtD
Acamprosate—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.00211	0.00273	CbGpPWpGaD
Acamprosate—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.0021	0.0149	CcSEcCtD
Acamprosate—Skin disorder—Metformin—polycystic ovary syndrome	0.00209	0.0148	CcSEcCtD
Acamprosate—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00208	0.0147	CcSEcCtD
Acamprosate—GRM5—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.00207	0.00269	CbGpPWpGaD
Acamprosate—GABRA1—Ion channel transport—TRPV6—polycystic ovary syndrome	0.00207	0.00268	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—LHB—polycystic ovary syndrome	0.00205	0.00265	CbGpPWpGaD
Acamprosate—Anorexia—Metformin—polycystic ovary syndrome	0.00205	0.0145	CcSEcCtD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.00205	0.00265	CbGpPWpGaD
Acamprosate—Hypotension—Metformin—polycystic ovary syndrome	0.00201	0.0142	CcSEcCtD
Acamprosate—GRM5—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.002	0.00259	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—NPB—polycystic ovary syndrome	0.00198	0.00256	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.00197	0.00255	CbGpPWpGaD
Acamprosate—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.00196	0.00254	CbGpPWpGaD
Acamprosate—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00196	0.0138	CcSEcCtD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—RUNX3—polycystic ovary syndrome	0.00196	0.00253	CbGpPWpGaD
Acamprosate—Paraesthesia—Metformin—polycystic ovary syndrome	0.00193	0.0136	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00193	0.0025	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00193	0.0025	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—SCT—polycystic ovary syndrome	0.00192	0.00249	CbGpPWpGaD
Acamprosate—Dyspnoea—Metformin—polycystic ovary syndrome	0.00192	0.0135	CcSEcCtD
Acamprosate—Somnolence—Metformin—polycystic ovary syndrome	0.00191	0.0135	CcSEcCtD
Acamprosate—Dyspepsia—Metformin—polycystic ovary syndrome	0.00189	0.0134	CcSEcCtD
Acamprosate—GABRA1—Ion channel transport—SCNN1A—polycystic ovary syndrome	0.00187	0.00242	CbGpPWpGaD
Acamprosate—Decreased appetite—Metformin—polycystic ovary syndrome	0.00187	0.0132	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00186	0.0131	CcSEcCtD
Acamprosate—Constipation—Metformin—polycystic ovary syndrome	0.00184	0.013	CcSEcCtD
Acamprosate—GRM5—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.00183	0.00237	CbGpPWpGaD
Acamprosate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.00182	0.00236	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—SPTBN4—polycystic ovary syndrome	0.00182	0.00236	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.00182	0.00235	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.00182	0.00235	CbGpPWpGaD
Acamprosate—GRIN2C—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.00179	0.00232	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.00179	0.00232	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—SPTBN4—polycystic ovary syndrome	0.00177	0.0023	CbGpPWpGaD
Acamprosate—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00177	0.0125	CcSEcCtD
Acamprosate—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00176	0.0124	CcSEcCtD
Acamprosate—Urticaria—Metformin—polycystic ovary syndrome	0.00171	0.0121	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.0017	0.0022	CbGpPWpGaD
Acamprosate—Abdominal pain—Metformin—polycystic ovary syndrome	0.0017	0.012	CcSEcCtD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.00167	0.00216	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.00165	0.00214	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.00165	0.00214	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.00165	0.00214	CbGpPWpGaD
Acamprosate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.00161	0.00209	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.00161	0.00208	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—CDH15—polycystic ovary syndrome	0.00159	0.00206	CbGpPWpGaD
Acamprosate—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.00159	0.00206	CbGpPWpGaD
Acamprosate—GRIN2C—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.00159	0.00206	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—CDH15—polycystic ovary syndrome	0.00155	0.00201	CbGpPWpGaD
Acamprosate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.00155	0.00201	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00154	0.002	CbGpPWpGaD
Acamprosate—Asthenia—Metformin—polycystic ovary syndrome	0.00154	0.0109	CcSEcCtD
Acamprosate—Pruritus—Metformin—polycystic ovary syndrome	0.00152	0.0107	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.0015	0.00194	CbGpPWpGaD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.00148	0.00191	CbGpPWpGaD
Acamprosate—Diarrhoea—Metformin—polycystic ovary syndrome	0.00147	0.0104	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.00146	0.00189	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.00146	0.00189	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—NGFR—polycystic ovary syndrome	0.00145	0.00188	CbGpPWpGaD
Acamprosate—SLC36A1—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	0.00143	0.00185	CbGpPWpGaD
Acamprosate—Dizziness—Metformin—polycystic ovary syndrome	0.00142	0.01	CcSEcCtD
Acamprosate—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.00141	0.00182	CbGpPWpGaD
Acamprosate—GRIN2C—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00138	0.00178	CbGpPWpGaD
Acamprosate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.00137	0.00177	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.00137	0.00177	CbGpPWpGaD
Acamprosate—Vomiting—Metformin—polycystic ovary syndrome	0.00137	0.00966	CcSEcCtD
Acamprosate—Rash—Metformin—polycystic ovary syndrome	0.00136	0.00958	CcSEcCtD
Acamprosate—Dermatitis—Metformin—polycystic ovary syndrome	0.00135	0.00957	CcSEcCtD
Acamprosate—GRM5—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.00135	0.00175	CbGpPWpGaD
Acamprosate—Headache—Metformin—polycystic ovary syndrome	0.00135	0.00952	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00134	0.00173	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.00133	0.00172	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00133	0.00172	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—SPTBN4—polycystic ovary syndrome	0.0013	0.00168	CbGpPWpGaD
Acamprosate—GRIN2D—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00128	0.00166	CbGpPWpGaD
Acamprosate—Nausea—Metformin—polycystic ovary syndrome	0.00128	0.00902	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—SPTBN4—polycystic ovary syndrome	0.00127	0.00164	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	0.00124	0.00161	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—NGFR—polycystic ovary syndrome	0.00124	0.00161	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.00122	0.00158	CbGpPWpGaD
Acamprosate—GRIN2C—Neuronal System—DLG4—polycystic ovary syndrome	0.00122	0.00157	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.00121	0.00157	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.00121	0.00157	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—NGFR—polycystic ovary syndrome	0.00121	0.00157	CbGpPWpGaD
Acamprosate—GABRB3—Orphan transporters—PLAT—polycystic ovary syndrome	0.00121	0.00156	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.0012	0.00155	CbGpPWpGaD
Acamprosate—GABRG2—Orphan transporters—PLAT—polycystic ovary syndrome	0.00118	0.00153	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.00118	0.00152	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.00117	0.00152	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NPB—polycystic ovary syndrome	0.00117	0.00151	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.00117	0.00151	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00116	0.0015	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.00116	0.0015	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.00113	0.00147	CbGpPWpGaD
Acamprosate—GRIN2D—Neuronal System—DLG4—polycystic ovary syndrome	0.00113	0.00146	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.00112	0.00145	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—RUNX3—polycystic ovary syndrome	0.00111	0.00143	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.00111	0.00143	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—AR—polycystic ovary syndrome	0.0011	0.00143	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.00109	0.00141	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.00106	0.00138	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.00106	0.00137	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.00106	0.00137	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—LHB—polycystic ovary syndrome	0.00105	0.00136	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00105	0.00136	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.00105	0.00136	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.00104	0.00134	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.00104	0.00134	CbGpPWpGaD
Acamprosate—GABRA1—Orphan transporters—PLAT—polycystic ovary syndrome	0.00103	0.00134	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.00103	0.00133	CbGpPWpGaD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.00103	0.00133	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.00103	0.00133	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.00101	0.00131	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—LEP—polycystic ovary syndrome	0.000994	0.00129	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000985	0.00128	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000976	0.00126	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000976	0.00126	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.00094	0.00122	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—DLG4—polycystic ovary syndrome	0.000928	0.0012	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.000927	0.0012	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000916	0.00119	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000913	0.00118	CbGpPWpGaD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.000911	0.00118	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.0009	0.00117	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	0.000894	0.00116	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000893	0.00116	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000886	0.00115	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—IRS2—polycystic ovary syndrome	0.000866	0.00112	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000862	0.00112	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000854	0.00111	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—IRS2—polycystic ovary syndrome	0.000844	0.00109	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—INHBB—polycystic ovary syndrome	0.00084	0.00109	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000839	0.00109	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000824	0.00107	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—NGFR—polycystic ovary syndrome	0.000818	0.00106	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—DLG4—polycystic ovary syndrome	0.00081	0.00105	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.000796	0.00103	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000794	0.00103	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—DLG4—polycystic ovary syndrome	0.000789	0.00102	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.000788	0.00102	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000784	0.00102	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.000774	0.001	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000765	0.00099	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000759	0.000982	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—IRS1—polycystic ovary syndrome	0.000756	0.000979	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000745	0.000964	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—IRS1—polycystic ovary syndrome	0.000737	0.000954	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000726	0.00094	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.00072	0.000932	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—DLG4—polycystic ovary syndrome	0.000718	0.00093	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000714	0.000925	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	0.000703	0.000911	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—DLG4—polycystic ovary syndrome	0.0007	0.000907	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000699	0.000905	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.000697	0.000903	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000694	0.000899	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.000685	0.000887	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.000677	0.000876	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000671	0.000869	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000653	0.000846	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000651	0.000843	CbGpPWpGaD
Acamprosate—GRIN1—EPH-Ephrin signaling—VEGFA—polycystic ovary syndrome	0.000643	0.000833	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—FST—polycystic ovary syndrome	0.000636	0.000824	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000633	0.000819	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000629	0.000814	CbGpPWpGaD
Acamprosate—GRIN2B—EPH-Ephrin signaling—VEGFA—polycystic ovary syndrome	0.000627	0.000812	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—AR—polycystic ovary syndrome	0.000626	0.00081	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—LHB—polycystic ovary syndrome	0.000621	0.000804	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000609	0.000789	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000607	0.000786	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000604	0.000782	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.000598	0.000775	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000593	0.000768	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000588	0.000761	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000587	0.00076	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SCT—polycystic ovary syndrome	0.000582	0.000754	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000575	0.000744	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—IRS2—polycystic ovary syndrome	0.000571	0.00074	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000555	0.000719	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000546	0.000707	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000541	0.000701	CbGpPWpGaD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000539	0.000698	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—DLG4—polycystic ovary syndrome	0.000534	0.000692	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000533	0.00069	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—DLG4—polycystic ovary syndrome	0.000525	0.000679	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000519	0.000671	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—DLG4—polycystic ovary syndrome	0.000513	0.000664	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.000509	0.000659	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	0.000506	0.000655	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000505	0.000654	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—DLG4—polycystic ovary syndrome	0.0005	0.000647	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—IRS1—polycystic ovary syndrome	0.000499	0.000646	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000498	0.000645	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.000496	0.000642	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.00048	0.000622	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—INSR—polycystic ovary syndrome	0.000476	0.000617	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.000468	0.000606	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—DLG4—polycystic ovary syndrome	0.000459	0.000594	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000453	0.000586	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000446	0.000577	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PGR—polycystic ovary syndrome	0.000441	0.000571	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000429	0.000555	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PLAT—polycystic ovary syndrome	0.00041	0.000531	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—GHRL—polycystic ovary syndrome	0.00041	0.000531	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000395	0.000512	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000391	0.000507	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—NCOR1—polycystic ovary syndrome	0.000384	0.000497	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000382	0.000494	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.00038	0.000492	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—NCOR1—polycystic ovary syndrome	0.000374	0.000485	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IL6—polycystic ovary syndrome	0.000371	0.00048	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000361	0.000468	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000359	0.000465	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PRL—polycystic ovary syndrome	0.000358	0.000463	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000345	0.000447	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000339	0.00044	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000317	0.00041	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—LEP—polycystic ovary syndrome	0.000316	0.000409	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000315	0.000408	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000311	0.000402	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—LEP—polycystic ovary syndrome	0.000308	0.000399	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.0003	0.000388	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000297	0.000384	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000294	0.000381	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000294	0.000381	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000289	0.000374	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—PPARG—polycystic ovary syndrome	0.000275	0.000356	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000272	0.000352	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—INS—polycystic ovary syndrome	0.00027	0.00035	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000269	0.000349	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—PPARG—polycystic ovary syndrome	0.000268	0.000347	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000264	0.000342	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—INS—polycystic ovary syndrome	0.000263	0.000341	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—AKT2—polycystic ovary syndrome	0.000261	0.000338	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—AKT2—polycystic ovary syndrome	0.000254	0.000329	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000253	0.000327	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000252	0.000326	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—LEP—polycystic ovary syndrome	0.000247	0.000319	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000243	0.000314	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—VEGFA—polycystic ovary syndrome	0.000239	0.000309	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—VEGFA—polycystic ovary syndrome	0.000233	0.000302	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000231	0.000299	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000226	0.000292	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000222	0.000287	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IRS1—polycystic ovary syndrome	0.00022	0.000285	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—POMC—polycystic ovary syndrome	0.000212	0.000274	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—INS—polycystic ovary syndrome	0.000211	0.000273	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000204	0.000264	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000204	0.000264	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000194	0.000251	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000194	0.000251	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000171	0.000221	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000168	0.000217	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000166	0.000215	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—IL6—polycystic ovary syndrome	0.000165	0.000214	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—IL6—polycystic ovary syndrome	0.000161	0.000209	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000156	0.000202	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000133	0.000172	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—IL6—polycystic ovary syndrome	0.000118	0.000153	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—IL6—polycystic ovary syndrome	0.000115	0.000149	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL6—polycystic ovary syndrome	9.21e-05	0.000119	CbGpPWpGaD
